|

R-CHOP Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since July 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Sun Yat-sen University1
  • AstraZeneca1

Indications

  • Cancer2
  • CD5 Positive1
  • Untreated Follicular Lymphoma1
  • Diffuse Large B-cell Lymphoma(DLBCL)1

Other1 trial

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
Phase 2

Huntsville, Alabama1 trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.